Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 80 peer-reviewed journal articles Updated
Cardiology

Atrial Conduction Disease: A Patient Guide

At a Glance

Atrial conduction disease affects the electrical signals in the heart’s upper chambers and may cause no symptoms or lead to fatigue, dizziness, or fainting. ECGs and intermittent or wearable monitors help clinicians match care to documented rhythms and assess the risk of atrial fibrillation.

Atrial conduction disease is a broad term used by some clinicians to describe related electrical issues that affect the upper chambers of the heart, known as the atria [1]. Unlike conditions that focus purely on how fast the heart beats, these disorders involve the heart’s “wiring”—the specialized pathways that carry electrical signals from your natural pacemaker to the rest of the heart muscle. When these pathways become slowed, blocked, or damaged, the heart struggles to coordinate its beats effectively, which can lead to a wide range of experiences for the patient [2].

The two main disorders often grouped under this label are Sinus Node Dysfunction, where the heart’s natural “power station” fails to send consistent signals, and Interatrial Block, where the signal is delayed as it travels from the right side of the heart to the left [3][4]. These issues are often associated with fibrosis, a process where healthy heart tissue is affected by stiff, scar-like changes linked to aging, high blood pressure, or inflammation [5]. While it is distinct from Atrial Fibrillation (AFib), which is a chaotic and irregular rhythm, conditions like advanced Interatrial Block are associated with an increased risk of AFib developing later on [6].

Living with these related atrial electrical disorders can feel very different from one person to the next. For many, isolated Interatrial Block is completely “silent” and only discovered during a routine medical exam, while Sinus Node Dysfunction can cause dramatic symptoms such as profound fatigue, dizziness, or even fainting [7][8]. Because the conditions vary so widely, the most crucial part of your care is often individualized surveillance—using intermittent or wearable monitors tailored to your risk to ensure that any new or hidden heart rhythms are caught [9].

Ultimately, the goal of management is to treat the person, not just the test results. Treatment decisions are driven primarily by your symptoms and documented rhythm changes rather than a single number on an electrocardiogram [10]. By focusing on appropriate monitoring and optimizing your heart’s overall health through lifestyle changes, you and your care team can proactively manage your heart’s “wiring” and maintain your quality of life [11].

In this guide

6 chapters

01

Understanding Atrial Conduction Disease

Learn what atrial conduction disease means, how SND and interatrial block differ, which ECG and monitor tests help diagnose it, and its link to AFib risk.

02

Symptoms and Warning Signs

Learn the symptoms of atrial conduction disease, including fatigue, dizziness, palpitations, fainting, and warning signs that require emergency care now.

03

Diagnostic Testing: ECGs, Holter Monitors, and Echocardiograms

Learn how ECGs, Holter monitors, patch monitors, and echocardiograms evaluate atrial conduction disease, including P-wave changes and symptom matching.

04

Surveillance and Lifestyle Management

Learn how atrial conduction disease is monitored for hidden AFib, and how weight, blood pressure, alcohol, and sleep apnea affect heart rhythm and stroke risk.

05

Treatment Strategies: When is Intervention Needed?

Learn when atrial conduction disease needs treatment, how reversible causes are checked, when a pacemaker may help, and why isolated IAB usually needs monitoring.

06

Long-term Risk: Bayés Syndrome, AFib, and Stroke

Learn how atrial conduction disease, Bayés syndrome, and advanced IAB affect AFib and stroke risk, including monitoring, FAST signs, and treatment decisions.

Common questions in this guide

What does atrial conduction disease mean?
Atrial conduction disease is a broad term for problems with the heart’s electrical signals in the atria, or upper chambers. It often includes sinus node dysfunction, in which the natural pacemaker sends inconsistent signals, and interatrial block, in which a signal travels slowly between the atria.
What symptoms might an atrial conduction problem cause?
Some people have no symptoms, especially with isolated interatrial block. Others may have fatigue, lightheadedness, dizziness, fainting, or episodes in which the heart feels fast and then slow. A clinician must compare symptoms with recorded rhythms because symptoms do not always come from the electrical finding.
Does this condition increase my chance of atrial fibrillation?
Advanced interatrial block is associated with a higher chance of atrial fibrillation in the future, but atrial conduction disease is not the same as AFib. The risk varies by the specific finding and your overall health, so your clinician may recommend monitoring for new or hidden rhythms.
How are atrial conduction problems found and followed?
An electrocardiogram, or ECG, can show an atrial electrical pattern, but a single result does not determine care by itself. Intermittent or wearable heart-rhythm monitors may be used to look for changes or rhythms that are not present during an office test, with the plan tailored to your symptoms and risk.
What treatment is usually needed?
Treatment is individualized and is guided mainly by symptoms and documented rhythm changes rather than one ECG number. Care may include planned rhythm monitoring and lifestyle measures that support heart health, such as working with your clinician to manage blood pressure and weight.

Get notified when new evidence is published on Atrial conduction disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    The cardiac conduction system: A narrative review.

    Kariman M, Pretterklieber B, Pretterklieber ML, et al.

    Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft 2026; (268()):152880 doi:10.1016/j.aanat.2026.152880.

    PMID: 42471220
  2. 2

    Sick Sinus Syndrome.

    De Ponti R, Marazzato J, Bagliani G, et al.

    Cardiac electrophysiology clinics 2018; (10(2)):183-195 doi:10.1016/j.ccep.2018.02.002.

    PMID: 29784479
  3. 3

    Sinus Node Dysfunction.

    Sathnur N, Ebin E, Benditt DG

    Cardiology clinics 2023; (41(3)):349-367 doi:10.1016/j.ccl.2023.03.013.

    PMID: 37321686
  4. 4

    Intra- and interatrial conduction abnormalities: hemodynamic and arrhythmic significance.

    Johner N, Namdar M, Shah DC

    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2018; (52(3)):293-302 doi:10.1007/s10840-018-0413-4.

    PMID: 30128800
  5. 5

    Assessment of atrial fibrosis for the rhythm control of atrial fibrillation.

    Begg GA, Holden AV, Lip GY, et al.

    International journal of cardiology 2016; (220()):155-61.

    PMID: 27389440
  6. 6

    P-wave duration and interatrial block as predictors of new-onset atrial fibrillation: A systematic review and meta-analysis.

    Zagoridis K, Koutalas E, Intzes S, et al.

    Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 2023; (72()):57-64 doi:10.1016/j.hjc.2023.03.007.

    PMID: 37028490
  7. 7

    [Sinus bradycardia and syncope: what pathophysiological mechanism and what management of the patient?]

    Alboni P, Stucci N, Parisi C

    Giornale italiano di cardiologia (2006) 2017; (18(11)):774-780 doi:10.1714/2803.28363.

    PMID: 29105672
  8. 8

    Resumption of interatrial conduction after atrial premature beat in baseline interatrial aberrancy.

    Rungpradubvong V

    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2021; (26(6)):e12838 doi:10.1111/anec.12838.

    PMID: 33629496
  9. 9

    A Patch-Type Electrocardiography Is Superior to Holter Monitoring for Detecting Paroxysmal Cardiac Arrhythmias.

    Kim YG, Choi JI, Oh IY, et al.

    Journal of Korean medical science 2025; (40(28)):e168 doi:10.3346/jkms.2025.40.e168.

    PMID: 40696526
  10. 10

    Symptomatic Long Pauses and Bradycardia due to Massive Multinodular Goiter.

    Deshmukh A, Ozcan C

    Case reports in cardiology 2017; (2017()):4201942 doi:10.1155/2017/4201942.

    PMID: 28845312
  11. 11

    Impact of risk-factor modification on arrhythmia recurrence among morbidly obese patients undergoing atrial fibrillation ablation.

    Donnellan E, Wazni OM, Kanj M, et al.

    Journal of cardiovascular electrophysiology 2020; (31(8)):1979-1986 doi:10.1111/jce.14607.

    PMID: 32510749

This page is for informational purposes only and does not constitute medical advice. Your cardiology team should interpret your ECG, symptoms, and personal risk when advising you about monitoring and care.